跳至主要内容
临床试验/NCT07045688
NCT07045688招募中不适用

Efficacy of Vonoprazan Based Dual and Triple Therapy for Naive Patient With Helicobacter Pylori Infection

Sohag University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年5月13日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
efficacy medical treatment for eradication of Helicobacter Pylori infection in naive patient.

研究概览

简要总结

This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: >18 years old.
  • H. pylori infection: Confirmed by histopathology or non-invasive tests (e.g., stool antigen test).

排除标准

  • Prior H. pylori treatment: Previous treatment for H. pylori infection.
  • Allergies: Known allergies to study medications or components.
  • Patients cannot finish treatment course.
  • Patient missed follow up.
  • Patients refusing or neglecting test of cure for H. pylori.

研究组 & 干预措施

Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection

Active Comparator

we assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient.

干预措施: Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection (Drug)

Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection

Active Comparator

we assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

干预措施: Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection (Drug)

Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection

Active Comparator

we assess the efficacy of proton pump inhibitors (PPI) based dual therapy for eradication of Helicobacter Pylori infection in naive patient.

干预措施: Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection (Drug)

结局指标

主要结局

efficacy medical treatment for eradication of Helicobacter Pylori infection in naive patient.

时间窗: 4 weeks after successful medical treatment

stool antigen for H. Pylori

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew Kamil Wadie

Resident,Internal Medicine Departement , Faculty of Medicine Sohag university

Sohag University

研究点 (1)

Loading locations...

相似试验